JCT> Vol.6 No.2, February 2015

Department of Digestive and General Surgery, Faculty of Medicine, Shimane University, Izumo, Japan
Department of Digestive and General Surgery, Faculty of Medicine, Shimane University, Izumo, Japan
Department of Surgery, Shimane Prefectural Central Hospital, Izumo, Japan
Department of Surgery, Shimane Prefectural Central Hospital, Izumo, Japan
Department of Gastroenterological Surgery, Matsue Red Cross Hospital, Matsue, Japan
Department of Surgery, National Hospital Organization Hamada Medical Center, Hamada, Japan
Department of Digestive and General Surgery, Faculty of Medicine, Shimane University, Izumo, Japan
Department of Surgery, Masuda Medical Association Hospital, Masuda, Japan
Department of Gastroenterological Surgery, Matsue Red Cross Hospital, Matsue, Japan
Department of Digestive and General Surgery, Faculty of Medicine, Shimane University, Izumo, Japan

 

Copyright © 2015 Tetsu Yamamoto, Ryoji Hyakudomi, Shinichi Sugimoto, Atsuo Tokuka, Yoshitoshi Sato, Satoshi Nagai, Hikota Hayashi, Masahikoo Igarashi, Kenji Takubo, Yoshitsugu Tajima et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article

---

Yamamoto, T. , Hyakudomi, R. , Sugimoto, S. , Tokuka, A. , Sato, Y. , Nagai, S. , Hayashi, H. , Igarashi, M. , Takubo, K. and Tajima, Y. (2015) A Multicenter Cohort Study for XELOX (Capecitabine, Leucovorin plus Oxaliplatin) Therapy as First-Line Treatment in Elderly Patients with Unresectable Colorectal Cancer. Journal of Cancer Therapy, 6, 153-162. doi: 10.4236/jct.2015.62017.

 

Download citation as EndNote